Connect with us

Published

on

The Hims app arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025. 

Gabby Jones | Bloomberg | Getty Images

Shares of Hims & Hers Health fell 28% on Tuesday, a day after the telehealth company released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business.

Hims & Hers reported $481 million in revenue for the quarter, up 95% from $246.6 million during the same period last year. Net income climbed to $26.01 million, or 11 cents per share, from $1.25 million, or 1 cent per share, a year prior. 

But the company’s gross margin, or the profit left after accounting for the cost of goods sold, was 77%, disappointing analysts who were expecting 78.4%, according to StreetAccount.

In the company’s quarterly call with investors on Monday, CFO Yemi Okupe said the scaling of the company’s GLP-1 offering and its strategic pricing options were to blame.

Hims & Hers in May started prescribing compounded semaglutide, the active ingredient in Novo Nordisk‘s GLP-1 weight loss medications Ozempic and Wegovy. Compounded drugs can be produced when brand-name treatments are in shortage, but the U.S. Food and Drug Administration announced Friday that the shortage of semaglutide injection products has been resolved.

As a result, Hims & Hers said Monday it will likely stop offering compounded semaglutide on its platform after its first quarter, though some consumers may still be able to access personalized doses if clinically applicable. The GLP-1 offering generated more than $225 million in revenue for the company in 2024.

“We will have to start notifying customers in the coming month or two that they will need to start looking for alternative options on the commercial dosing,” Hims & Hers CEO Andrew Dudum said on the call. 

Going forward, the company said its weight loss offerings will primarily consist of its oral medications and the injectable medication liraglutide, which it plans to introduce on its platform this year.

Analysts at Morgan Stanley said in a note Tuesday the company’s report was “a lot to digest.” They maintained their equal weight rating on the stock and said they were surprised by the magnitude of the company’s 2025 guidance.

Hims & Hers said it expects between $2.3 billion to $2.4 billion in revenue this year. The company added that it expects its weight loss offerings to generate at least $725 million in revenue, excluding contributions from compounded semaglutide.

“We remain positive on the long-term opportunity, highlighting the company’s attractive platform and solid track record that differentiate it relative to digital health and DTC comps,” the Morgan Stanley analysts said.

Bank of America analysts said that while the company might have some success transitioning patients to its other weight loss offerings like its oral medications, it will face a “significant execution risk” as supply of brand-name GLP-1s increases.

Additionally, the analysts said Hims & Hers’ competitors will likely shift marketing dollars back to other products for conditions like erectile dysfunction and hair loss, which could put pressure on its advertising costs. They reiterated their underperform rating on the stock.

“Overall, we do not see upside to 2025 revenue guidance and think the beat and raise story is likely over in the near-term,” the Bank of America analysts wrote in a note Tuesday.

Citi analysts meanwhile said they think Hims & Hers revenue guidance is “aspirational,” as it would require “significant acceleration” in the use of its other weight loss products. They said they are less confident about the success of these offerings.

Even so, the analysts increased their price target on the stock to $27 from $25.

“We await a more compelling entry point and more details on growth ex-GLP-1s before we become more constructive,” they wrote in a Monday note.

–CNBC’s Michael Bloom contributed to this report

Continue Reading

Technology

Tesla’s market cap sinks below $1 trillion as stock slumps more than 9%

Published

on

By

Tesla's market cap sinks below  trillion as stock slumps more than 9%

Elon Musk, chief executive officer of Tesla Inc., in the Oval Office of the White House in Washington on Tuesday, Feb. 11, 2025.

Aaron Schwartz | Bloomberg | Getty Images

Tesla’s post-election pop has almost disappeared.

Shares of the electric vehicle maker plunged by more than 9% on Tuesday, pushing the company’s market cap below $1 trillion and to its lowest since Nov. 7, which was two days after President Donald Trump’s election victory.

The stock has plummeted 25% to start the year, while the Nasdaq is down just 1.3%, and has slid 35% from its record close on Dec. 16. CEO Elon Musk has lost more than $100 billion in net worth over that stretch, though he’s still the world’s richest person, with a fortune valued at about $380 billion.

The latest slide followed a report from Reuters on Monday that Tesla’s long-awaited upgrade to its partially automated driving systems left owners disappointed. Many users told the publication that Tesla’s “navigate on city streets” feature in China fell short of Musk’s promises for self-driving technology.

Other EV makers in China, including BYD, offer their partially automated driving systems for free or a much lower cost. Xiaomi’s popular model SU7 includes the company’s equivalent technology as a standard option for free.

The report out of China added to anxiety amongst Tesla shareholders. Some of the concern has to do with the company’s performance and some is specific to Musk, who is spending much of his time in Washington, DC., leading President Trump’s so-called Department of Government Efficiency (DOGE).

Musk, along with his team in Washington, has gained unparalleled access to government computer systems and taxpayer data, and the president has enabled the billionaire to lead mass firings of workers in agencies tasked with oversight of his companies, including Tesla.

Musk’s extremist political rhetoric and activism has led opponents in various markets to organize protests, including at Tesla stores and service centers. Tesla’s stock dropped earlier this month on Trump’s announced plans for extensive tariffs on goods from Canada, Mexico and China, which came alongside a decline in Tesla vehicle registrations across Europe in January and February.

For the fourth quarter, Tesla reported earnings and sales that missed analysts’ estimates, with automotive revenue dropping 8% from a year earlier and operating income plummeting 23%. In the late January report, the company cited reduced average selling prices across its aging lineup of Model 3, Model Y, Model S and Model X vehicles as a major reason for the decline.

According to the California New Car Dealers Association, Tesla sales dropped 11.6% in the fourth quarter of 2024 in the state, which had been Tesla’s biggest market domestically.

Tesla shares are now about 19% above where they were trading prior to Trump’s victory. Most of what remains of the rally is due to the stock’s 15% jump the day after the election. Musk was a major backer of Trump’s presidential effort, contributing $290 million to Republican candidates and causes in 2024, most of that directed at returning Trump to the White House.

Musk and Tesla didn’t immediately respond to requests for comment.

WATCH: Tesla stock hinges on new vehicles being introduced

Tesla stock hinges on new vehicles being introduced, says Canaccord's  George Gianarikas

Continue Reading

Technology

Super Micro shares fall ahead of filing deadline

Published

on

By

Super Micro shares fall ahead of filing deadline

The Super Micro Computer Inc. headquarters in San Jose, California, US, on Tuesday, Dec. 3, 2024. 

David Paul Morris | Bloomberg | Getty Images

Super Micro Computer shares fell as much as 10% during trading on Tuesday as the company nears a deadline to file audited financial reports or be delisted from the Nasdaq exchange.

Earlier this month, Super Micro CEO Charles Liang told investors he was “confident” that the company could file those reports to the U.S. Securities and Exchange Commission by Feb. 25, a deadline set by Nasdaq. The company must file its audited annual report for fiscal 2024 and the first two quarters of fiscal 2025.

If Super Micro fails to file the reports, its stock could be delisted from Nasdaq. It could also ask for another extension of up to 180 days.

Super Micro representatives did not respond to CNBC’s request for comment.

Read more CNBC tech news

Last fall, Super Micro shares slumped in August after the company delayed releasing its annual report for the year ending in June. Ernst & Young, the company’s auditor, quit citing governance issues in October. Super Micro named BDO as its new auditor in November. The company has also been targeted by an activist short seller, Hindenburg Research, which alleged accounting fraud.

The uncertainty has led to a roller coaster for the stock. It plunged last year to a low of about $18 per share in November after soaring more than 14-fold from the end of 2022 to its peak in March last year. So far in 2025, Super Micro’s stock price has risen more than 55%.

Throughout this saga, Super Micro has risen to a higher level of prominence as its revenue has surged as a result of the boom in artificial intelligence. The biggest driver of Super Micro’s growth is that it sells systems based around Nvidia graphics processing units, or GPUs, needed to build server clusters for AI. Elon Musk’s xAI, for example, buys Super Micro systems.

According to its unaudited financials, Super Micro sales more than doubled in its fiscal 2024 to $14.94 billion. Analysts expect about $5.37 billion in revenue for the current quarter, which would be a nearly 40% increase year over year.

The SEC’s system for accepting filings can receive documents as late as 10 p.m. ET, and depending on how late the filing is made, it can become public the next morning.

— CNBC’s Samantha Subin and Kristina Partsinevelos contributed to this report.

WATCH: Super Micro Computer cuts full year revenue guidance

Super Micro Computer cuts full year revenue guidance

Continue Reading

Technology

Perplexity AI launching $50 million venture fund to back early-stage startups

Published

on

By

Perplexity AI launching  million venture fund to back early-stage startups

Perplexity AI logo is seen in this illustration taken January 4, 2024. 

Dado Ruvic | Reuters

Perplexity AI, the developer of a popular artificial intelligence search engine, is close to raising a $50 million venture fund focused on early-stage AI startups, CNBC has learned.

The company will be an anchor investor in the fund, but most of the capital is coming from outside limited partners, according to a person familiar with the matter who asked not to be named because the information is confidential.

The two general partners of the fund are also coming from elsewhere. They are Kelly Graziadei and Joanna Lee Shevelenko, who have been running early-stage fund f7 Ventures, the person said.

Perplexity has been in the middle of the generative AI boom that began in late 2022 with the launch of OpenAI’s ChatGPT. CNBC reported in November that the company was in the final stages of raising $500 million in funding at a $9 billion valuation. Perplexity is viewed as a potential competitor to Google as more consumers turn to AI to search for information online.

Last month, Perplexity also made a bid to merge with TikTok U.S. as the social media platform faces a potential U.S. shutdown.

The company sees a potential investing advantage when it comes to startups because roughly 80,000 developers are plugged into its network, so Perplexity gets visibility into who is using its application programming interface (API) and who is most active in their consumption, the person said.

Perplexity’s founders and investors are putting money into the fund, and some of the company’s commitment is in the form of stock, the source said.

— CNBC’s Samantha Subin contributed to this report.

WATCH: Perplexity’s case for U.S. TikTok ownership

Perplexity's case for U.S. TikTok ownership

Continue Reading

Trending